BGY-1601

N/A

Report date: 2025/08/27 17:31:55

Base Information

Drug NameBGY-1601
Drug Alias Namebacterial strain Lacticaseibacillus rhamnosus Lcr35BGY-1601
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsFemale Urogenital Diseases and Pregnancy ComplicationsCandidiasis, VulvovaginalVaginosis, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNEXBIOME Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesNEXBIOME Therapeutics
Inactive CompaniesN/A
Active IndicationsFemale Urogenital Diseases and Pregnancy ComplicationsCandidiasis, VulvovaginalVaginosis, Bacterial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A